California Congressman receives CHI's first-ever Leadership Award

Published on April 7, 2011 at 8:16 AM · No Comments

Congressman and Majority Whip Kevin McCarthy (CA-22), was honored by CHI-California Healthcare Institute with the organization's first-ever Leadership Award. The award was presented by CHI Chairman Carl W. Hull, president and chief executive officer, Gen-Probe Incorporated; David L. Gollaher, Ph.D. president and CEO, CHI; David W. Beier, senior vice president, Global Government and Corporate Affairs, Amgen; John C. Martin, Ph.D., chairman and CEO, Gilead Sciences, and Steve E. Krognes, senior vice president and chief financial officer, Genentech, at a CHI dinner in Washington, D.C.

"Congressman McCarthy, since we first gave him our Visionary Award in 2005 when he was serving in the California Assembly, has been a leader in supporting the state's biomedical industry in its quest to maintain its innovation edge in the increasingly competitive 21st century economy," said David Gollaher, Ph.D., CHI's president and CEO. "Now in only his third term in Congress, we are pleased to recognize him again for his continued leadership, such as through support of the pro-innovation biosimilars legislation, opposition to government price control efforts such as through drug importation and the Medicare Independent Payment Advisory Board, and his opposition to the medical device tax."

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Dansk | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment